This invention is in the area of methods and compositions for the inhibition of the expression of VCAM-1 and, in particular, for the treatment of diseases mediated by VCAM-1, including cardiovascular and inflammatory diseases. The method further comprises providing of the encoded representations to an end user. The vinylacetate is copolymerized with polyethylene.